全球抗發炎治療藥物市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計抗發炎藥物市場將從 2025 年的 1,166.5 億美元成長到 2034 年的 1,914.6 億美元，2026 年至 2034 年的複合年成長率為 5.66%。

由於關節炎、氣喘、發炎性腸道疾病和自體免疫疾病等發炎性疾病的盛行率不斷上升，全球抗發炎藥物市場正經歷穩定成長。慢性發炎已成為全球主要的健康問題，推動了對有效治療方案的需求。製藥公司正致力於研發先進的抗發炎藥物，以幫助緩解症狀並提高患者的生活品質。

該市場的成長受多種因素驅動，包括藥物研發技術的進步、健康意識的提高以及對藥物研發投入的增加。生物製藥療法和標靶治療因其能夠提供更精準的治療效果而日益普及。此外，全球人口老化和文明病的增加也進一步推動了整個醫療保健系統對抗發炎藥物的需求。

未來幾年，全球抗發炎藥物市場預計將受益於持續的創新和不斷擴大的臨床研究。製藥公司正在探索新的藥物類別和聯合治療，以增強治療效果。個人化醫療和生物製藥的日益普及也有望為市場成長開闢新的途徑。隨著醫療保健支出的增加和醫療技術的不斷進步，抗發炎藥物市場預計將顯著擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球抗發炎治療藥物市場：依藥物類別分類

• 市場分析、洞察與預測
• 抗發炎生物製藥
• 非類固醇消炎劑（NSAIDs）
• 其他

第5章 全球抗發炎治療藥物市場：依應用分類

• 市場分析、洞察與預測
• 自體免疫疾病
• 呼吸系統疾病
• 其他

第6章 全球抗發炎治療藥物市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 注射
• 局部行政部門
• 吸入

第7章 全球抗發炎治療藥物市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第8章 全球抗發炎治療藥物市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AbbVie Inc
  • Merck & Co. Inc
  • Johnson & Johnson Services Inc
  • Pfizer Inc
  • Novartis AG
  • GlaxoSmithKline Plc
  • Amgen Inc
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Sanofi

The Anti-inflammatory Therapeutics Market size is expected to reach USD 191.46 Billion in 2034 from USD 116.65 Billion (2025) growing at a CAGR of 5.66% during 2026-2034.

The Global Anti-inflammatory Therapeutics Market is experiencing steady growth due to the increasing prevalence of inflammatory diseases such as arthritis, asthma, inflammatory bowel disease, and autoimmune disorders. Chronic inflammation has become a major health concern globally, leading to a rising demand for effective therapeutic solutions. Pharmaceutical companies are focusing on developing advanced anti-inflammatory drugs that help reduce symptoms and improve patient quality of life.

Several factors are contributing to the growth of this market, including advancements in drug discovery, increasing healthcare awareness, and growing investments in pharmaceutical research and development. Biologic therapies and targeted treatments are gaining popularity due to their ability to provide more precise treatment outcomes. Additionally, the aging global population and rising incidence of lifestyle-related diseases are further driving the demand for anti-inflammatory medications across healthcare systems.

In the coming years, the Global Anti-inflammatory Therapeutics Market is expected to benefit from continued innovation and expanding clinical research. Pharmaceutical companies are exploring new drug classes and combination therapies to enhance treatment effectiveness. The increasing adoption of personalized medicine and biologic therapies is also expected to open new avenues for market growth. With rising healthcare spending and ongoing medical advancements, the anti-inflammatory therapeutics market is poised for significant expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Class

• Anti-inflammatory Biologics
• NSAIDs
• Others

By Application

• Auto-Immune Diseases
• Respiratory Conditions
• Others

By Route of Administration

• Oral
• Injection
• Topical
• Inhalation

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• AbbVie Inc, Merck Co Inc, Johnson Johnson Services Inc, Pfizer Inc, Novartis AG, GlaxoSmithKline plc, Amgen Inc, F HoffmannLa Roche Ltd, AstraZeneca, Sanofi
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Anti-inflammatory Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. NSAIDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Auto-Immune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Conditions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inhalation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Drug Class
  • 8.2.2 By Application
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Drug Class
  • 8.3.2 By Application
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Drug Class
  • 8.4.2 By Application
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Drug Class
  • 8.5.2 By Application
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Drug Class
  • 8.6.2 By Application
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANTI-INFLAMMATORY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AbbVie Inc
  • 10.2.2 Merck & Co. Inc
  • 10.2.3 Johnson & Johnson Services Inc
  • 10.2.4 Pfizer Inc
  • 10.2.5 Novartis AG
  • 10.2.6 GlaxoSmithKline Plc
  • 10.2.7 Amgen Inc
  • 10.2.8 F. Hoffmann-La Roche Ltd
  • 10.2.9 AstraZeneca
  • 10.2.10 Sanofi